1. Long-Term Anticoagulation for Patients Receiving Dialysis.
- Author
-
Nigwekar, Sagar U. and Thadhani, Ravi
- Subjects
- *
APIXABAN , *ATRIAL fibrillation treatment , *WARFARIN , *ATRIAL fibrillation , *HEMODIALYSIS patients , *PATIENTS , *ANTICOAGULANTS , *CHRONIC kidney failure , *COMPARATIVE studies , *HEMODIALYSIS , *HETEROCYCLIC compounds , *RESEARCH methodology , *MEDICAL cooperation , *PYRIDINE , *RESEARCH , *EVALUATION research - Abstract
The article focuses on a study examining the outcomes associated with the use of apixaban, an oral factor Xa inhibitor, in atrial fibrillation patients, published in this issue. It refers to 9.2% of patients who were prescribed apixaban while warfarin was used to treat the remaining. It highlights a remarkable increase in the number of new apixaban prescriptions.
- Published
- 2018
- Full Text
- View/download PDF